Simon P. Harding
University Of Liverpool And St Paul's Eye Unit, Merseyside
Liverpool, ENG, United Kingdom
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.
Journal: Health technology assessment (Winchester, England)
Published: May 12, 2026
Functional and structural biomarkers linked to diabetic retinal neurodegeneration in pre-clinical and early diabetic retinopathy.
Journal: BMC ophthalmology
Published: October 07, 2025
Metformin and incidence of age-related macular degeneration in people with diabetes: a population-based 5-year case-control study.
Journal: BMJ open ophthalmology
Published: June 05, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: October 29, 2024
Pharmacist prescribing in cancer services: A scoping review.
Journal: Research in social & administrative pharmacy : RSAP
Published: July 15, 2024
Effect of Fenofibrate on Progression of Diabetic Retinopathy.
Journal: NEJM evidence
Published: June 21, 2024
A qualitative evaluation of the effectiveness of behaviour change techniques used in the Healthy Eating and Active Lifestyles for Diabetes (HEAL-D) intervention.
Journal: BMC public health
Published: May 17, 2024
The future of academic integrity in the age of artificial intelligence.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: January 17, 2024
Whole systems approach to diet and healthy weight: a longitudinal process evaluation in East Scotland.
Journal: Perspectives in public health
Published: October 30, 2023
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Real-world UK Clinical Practice.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: September 20, 2023
Last Updated: 09/26/2026